PAPER Tercjak A, Bergareche A, Caballero C, Tuñon T, Linazasoro G
SEARCH RESULTS
330986 RESULTS
PAPER Atkin JD, Farg MA, Soo KY, Walker AK, Halloran M, Turner BJ, Nagley P, Horne MK
Mutant SOD1 inhibits ER-Golgi transport in Amyotrophic Lateral Sclerosis.
J Neurochem. 2013 Oct 18; PubMed: 24134191PAPER Shi Q, Song QQ, Sun P, Zhang J, Song J, Chen LN, Xiao K, Wang SB, Zhang YZ, Li GQ, Sheng LJ, Wang BD, Lu MZ, Han J, Dong XP
Infection of Prions and Treatment of PrP106-126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway.
Mol Neurobiol. 2013 Oct 18; PubMed: 24135906PAPER Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A
α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
Brain Struct Funct. 2013 Oct 18; PubMed: 24135772PAPER Christou YA, Ohyama K, Placzek M, Monk PN, Shaw PJ
Wild-type but not mutant SOD1 transgenic astrocytes promote the efficient generation of motor neuron progenitors from mouse embryonic stem cells.
BMC Neurosci. 2013 Oct 17;14(1):126. PubMed: 24134124PAPER Deng J, Shen C, Wang Y, Zhang M, Yan J, Fu X, Chen Y, Zhou H
Association between the polymorphism of estrogen receptor alpha and Alzheimer's disease in Chinese population.
Clin Lab. 2013;59(7-8):741-6. PubMed: 24133901PAPER Gong HC, Wang YL, Wang HW
[Epigenetic mechanisms of Alzheimer's disease and related drug research].
Yao Xue Xue Bao. 2013 Jul;48(7):1005-13. PubMed: 24133967PAPER Herholz SC, Herholz RS, Herholz K
Non-pharmacological interventions and neuroplasticity in early stage Alzheimer's disease.
Expert Rev Neurother. 2013 Nov;13(11):1235-45. PubMed: 24134650PAPER Hoppe JB, Haag M, Whalley BJ, Salbego CG, Cimarosti H
Curcumin protects organotypic hippocampal slice cultures from Aβ1-42-induced synaptic toxicity.
Toxicol In Vitro. 2013 Oct 14; PubMed: 24134851PAPER Rivasseau Jonveaux T, Batt M, Empereur F, Braun M, Trognon A
[Evaluation of temporality semantic knowledge in normal aging and in mild and moderate stages of Alzheimer's disease.]
Encephale. 2013 Oct 14; PubMed: 24135028PAPER Theleritis C, Politis A, Siarkos K, Lyketsos CG
A review of neuroimaging findings of apathy in Alzheimer's disease.
Int Psychogeriatr. 2013 Oct 18;:1-13. PubMed: 24135083PAPER Breitner JC
What should we do if we were wrong and Alzheimer was right?
Int Psychogeriatr. 2013 Oct 18;:1-4. PubMed: 24135193PAPER Léger GC, Banks SJ
Neuropsychiatric Symptom Profile Differs Based on Pathology in Patients with Clinically Diagnosed Behavioral Variant Frontotemporal Dementia.
Dement Geriatr Cogn Disord. 2013 Oct 10;37(1-2):104-112. PubMed: 24135712PAPER Hoffmann K, Frederiksen KS, Sobol NA, Beyer N, Vogel A, Simonsen AH, Johannsen P, Lolk A, Terkelsen O, Cotman CW, Hasselbalch SG, Waldemar G
Preserving Cognition, Quality of Life, Physical Health and Functional Ability in Alzheimer's Disease: The Effect of Physical Exercise (ADEX Trial): Rationale and Design.
Neuroepidemiology. 2013;41(3-4):198-207. PubMed: 24135720PAPER Alladi S, Shailaja M, Mridula KR, Haritha CA, Kavitha N, Khan SA, Divyaraj G, Kaul S
Mild Cognitive Impairment: Clinical and Imaging Profile in a Memory Clinic Setting in India.
Dement Geriatr Cogn Disord. 2013 Oct 10;37(1-2):113-124. PubMed: 24135787Current Filters
No filters selected